XOMA vs XOMAP

XOMA Royalty Corporation vs XOMA Royalty Corporation - 8.62 — Valuation Comparison 2026

XOMA

Biotechnology
XOMA Royalty Corporation
Quality
8.2
out of 10
Value Trap
20
SAFE
Price
$41.70
Last close
Models
13/13
Active
VS

XOMAP

Biotechnology
XOMA Royalty Corporation - 8.62
Quality
8.2
out of 10
Value Trap
20
SAFE
Price
$25.45
Last close
Models
13/13
Active

Model-by-Model Comparison

ModelType XOMA Fair ValueXOMA Upside XOMAP Fair ValueXOMAP Upside
Bayesian DCF Intrinsic $9.87 -76.4% $18.97 -25.2%
Earnings Power Value Intrinsic $2.83 -93.2% $4.93 -80.6%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for XOMA vs XOMAP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

XOMA vs XOMAP — Which Stock Is More Undervalued?

XOMAP scores higher with a 8.2/10 quality rating vs XOMA's 8.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing XOMA Royalty Corporation (XOMA) and XOMA Royalty Corporation - 8.62 (XOMAP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

XOMA currently trades at $41.70 with a QOC of 8.2/10, while XOMAP trades at $25.45 with a QOC of 8.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).